Macrophage migration inhibitory factor and the risk of myocardial infarction or death due to coronary artery disease in adults without prior myocardial infarction or stroke: the EPIC-Norfolk Prospective Population study

The American Journal of Medicine
S Matthijs BoekholdtKay-Tee Khaw

Abstract

To determine whether plasma levels of macrophage migration inhibitory factor, a proinflammatory cytokine involved in atherogenesis, are predictive of myocardial infarction or death from coronary artery disease. We performed a prospective case-control study nested in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Norfolk cohort. We selected men and women who did not report a history of myocardial infarction or stroke at baseline. Baseline concentrations of macrophage migration inhibitory factor were measured among 777 patients who had a myocardial infarction or died of coronary artery disease during follow-up, and 1554 matched controls who remained free of coronary artery disease. Baseline macrophage migration inhibitory factor concentrations were higher in cases than controls (median, 107.4 microg/L vs. 90.7 microg/L, P = 0.001). The risk of myocardial infarction or death from coronary artery disease increased with increasing quartiles of macrophage migration inhibitory factor (P for linearity <0.0001). Patients in the highest quartile had the greatest likelihood of myocardial infarction or death due to coronary artery disease (unadjusted odds ratio [OR] = 1.6; 95% confidence interval [CI]: 1.2 to 2.0)....Continue Reading

References

Apr 3, 1997·The New England Journal of Medicine·P M RidkerC H Hennekens
Sep 6, 2000·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·E YamaguchiY Kawakami
Jan 31, 2002·Arthritis and Rheumatism·Cristina MeazzaFabrizio De Benedetti
Apr 5, 2002·Microbes and Infection·Hongqi LueJürgen Bernhagen
Jul 3, 2002·Circulation·Stefan BlankenbergUNKNOWN AtheroGene Investigators
Jul 19, 2002·The New England Journal of Medicine·Stefan KiechlDavid A Schwartz
Sep 26, 2002·The Journal of Biological Chemistry·Hong LiaoRobert A Mitchell
Dec 17, 2002·Arteriosclerosis, Thrombosis, and Vascular Biology·Nancy S JennySteve E Humphries
Dec 20, 2002·Nature·Peter Libby
Jan 1, 2003·The American Journal of Pathology·Gunter Fingerle-RowsonRichard Bucala
Mar 14, 2003·The Journal of Pathology·Kar Neng LaiHui Yao Lan
Mar 21, 2003·The New England Journal of Medicine·Christopher HeeschenUNKNOWN CAPTURE Study Investigators
May 14, 2003·Circulation·S Matthijs BoekholdtUNKNOWN REgression GRowth Evaluation Statin Study Group
Jun 5, 2003·The Journal of Experimental Medicine·Lin LengRichard Bucala
Sep 23, 2003·Nature Reviews. Immunology·Thierry Calandra, Thierry Roger

❮ Previous
Next ❯

Citations

Nov 1, 2012·BMC Medical Research Methodology·F Lucy WrightUNKNOWN Million Women Study Collaborators
Jul 21, 2010·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Benoit J ArsenaultS Matthijs Boekholdt
Sep 9, 2010·The British Journal of General Practice : the Journal of the Royal College of General Practitioners·Parinya ChamnanSimon J Griffin
Mar 29, 2014·Cardiovascular Research·Tienush RassafJürgen Bernhagen
Jun 13, 2015·Thrombosis and Haemostasis·Sanne Bøjet LarsenSteen Dalby Kristensen
Jun 3, 2009·Clinical Endocrinology·S Matthijs BoekholdtKay-Tee Khaw
Jul 16, 2015·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Emiel P C van der VorstChristian Weber
May 28, 2013·Free Radical Biology & Medicine·Julia SobierajskiTienush Rassaf
Jun 13, 2013·Clinical Biochemistry·Lee StonerJames Faulkner
Feb 26, 2015·PloS One·Erlend T AasheimNicholas J Wareham
Feb 22, 2012·European Journal of Preventive Cardiology·Ersen B ColkesenKay-Tee Khaw
Apr 1, 2011·European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology·Lysette N BroekhuizenNicholas J Wareham
Oct 10, 2007·Circulation·Rakesh S BirjmohunS Matthijs Boekholdt

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.